anmelden
OMX Nordic 40
2.616,23
PKT
+12,38
PKT
+0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.05.18 | AstraZeneca Hold | S&P Capital IQ | |
| 22.05.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 22.05.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 22.05.18 | AstraZeneca overweight | Barclays Capital | |
| 22.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.05.18 | AstraZeneca buy | Deutsche Bank AG | |
| 18.05.18 | AstraZeneca Neutral | UBS AG | |
| 18.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 15.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.05.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.05.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 11.05.18 | AstraZeneca overweight | Barclays Capital | |
| 08.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.05.18 | Nokia overweight | JP Morgan Chase & Co. | |
| 04.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 03.05.18 | Novo Nordisk Verkaufen | DZ BANK | |
| 03.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.05.18 | Novo Nordisk buy | UBS AG | |
| 03.05.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 03.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.05.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.05.18 | Novo Nordisk buy | UBS AG | |
| 02.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.18 | Nokia overweight | Barclays Capital | |
| 30.04.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 27.04.18 | Nokia buy | S&P Capital IQ | |
| 27.04.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 27.04.18 | Nokia Neutral | Credit Suisse Group | |
| 26.04.18 | Nokia buy | Kepler Cheuvreux | |
| 26.04.18 | Nokia buy | UBS AG | |
| 26.04.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 26.04.18 | Nokia overweight | JP Morgan Chase & Co. | |
| 25.04.18 | Novo Nordisk buy | UBS AG | |
| 25.04.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 25.04.18 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 24.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. |